Heenan v. Commissioner of Social Security Administration

CourtDistrict Court, N.D. Ohio
DecidedMay 28, 2025
Docket5:24-cv-01423
StatusUnknown

This text of Heenan v. Commissioner of Social Security Administration (Heenan v. Commissioner of Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Heenan v. Commissioner of Social Security Administration, (N.D. Ohio 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

CONOR HEENAN, CASE NO. 5:24-CV-01423-BMB

Plaintiff, JUDGE BRIDGET M. BRENNAN

vs. MAGISTRATE JUDGE DARRELL A. CLAY

COMMISSIONER OF SOCIAL SECURITY REPORT AND RECOMMENDATION ADMINISTRATION,

Defendant.

INTRODUCTION Plaintiff Conor Heenan challenges the Commissioner of Social Security’s decision denying disability insurance benefits (DIB) and supplemental security income (SSI). (ECF #1). The District Court has jurisdiction under 42 U.S.C. §§ 1383(c) and 405(g). On August 21, 2024, under Local Civil Rule 72.2, this matter was referred to me to prepare a Report and Recommendation. (Non- document entry of Aug. 21, 2024). Briefing was completed as of January 2025. (See ECF #11). Following review, and for the reasons below, I recommend the District Court REVERSE the Commissioner’s decision and REMAND for further proceedings consistent with this Report and Recommendation. PROCEDURAL BACKGROUND Mr. Heenan applied for DIB on October 1, 2021, and for SSI on November 9, 2021, alleging he became disabled on September 26, 2020. (Tr. 216-18). The claims were denied initially on February 10, 2022 (Tr. 83, 92) and on reconsideration on November 16, 2022 (Tr. 101, 110). On December 13, 2022, Mr. Heenan requested a hearing before an administrative law judge. (Tr. 146). On July 12, 2023, Mr. Heenan (represented by counsel) and a vocational expert (VE) testified before the ALJ. (Tr. 42-74). On August 8, 2023, the ALJ determined Mr. Heenan

was not disabled. (Tr. 14-41). On June 18, 2024, the Appeals Council denied Mr. Heenan’s request for review, making the hearing decision the final decision of the Commissioner. (Tr. 1-6; see 20 C.F.R. §§ 404.981; 416.1481). Mr. Heenan timely filed this action on August 21, 2024. (ECF #1). FACTUAL BACKGROUND I. Personal and Vocational Evidence Mr. Heenan was 27 years old when he filed his applications and 30 years old at the

hearing. (See Tr. 84). He attended two years of college but stopped due to his symptoms. (Tr. 52). He has worked in restaurants as a bartender and server, repaired telephones, and trained for a sales position. (Tr. 69). II. Relevant Medical Evidence Mr. Heenan has a history of waxing and waning depression and anxiety with symptoms of low energy, fatigue, and amotivation. Medical records show he frequently and consistently

attended psychiatric appointments and individual counseling sessions. At these appointments, mental-status examinations were largely normal, with abnormalities mainly noted in Mr. Heenan’s mood and affect. (See, e.g., Tr. 280, 283, 288, 289, 291, 294, 298, 316, 350, 360, 368, 375, 382, 390, 398, 406, 413, 418, 423, 430, 460, 487, 585, 691, 723). At times, Mr. Heenan appeared disheveled and unkempt. (Tr. 333, 422, 444, 447). He often admitted to passive suicidal ideation, such as desiring to fall asleep and not wake up but did not have a plan or intent. (Tr. 334, 417, 421, 423, 429, 432, 435, 438, 441, 444, 447, 459, 471, 474, 480, 489). The following summary shows the frequency of Mr. Heenan’s mental-health-treatment sessions, the medication changes he underwent to relieve his symptoms, and statements he made to medical providers about his

symptoms between late 2019 and 2023: 2019. In December, Mr. Heenan met with a mental health nurse practitioner working with Bharat J. Shah, M.D., and reported continued depression, low energy, and amotivation. (Tr. 280). At the time, Mr. Heenan was taking Cymbalta, Effexor, and Abilify for his symptoms.1 (Id.). The nurse ordered him to wean off Cymbalta gradually. (Id.). Later that month, Mr. Heenan reported some feelings of depression, anxiety, low energy, and amotivation. (Tr. 281). The nurse directed

him to stop taking Cymbalta and gradually increase Effexor. (Id.). 2020. On January 3, Mr. Heenan expressed concern that the higher dose of Effexor worsened his anxiety. (Tr. 282). The nurse added a prescription for Pristiq2 and ordered Mr. Heenan to decrease Effexor gradually and continue taking Abilify. (Id.). On January 16, Mr. Heenan reported no longer taking Effexor due to increased anxiety. (Tr. 283). The nurse continued Abilify and increased the dose of Pristiq. (Id.). On January 31, Mr. Heenan reported

1 Cymbalta and Effexor are two brand-name medications prescribed to treat anxiety and depression. See Duloxetine, MedlinePlus, http://medlineplus.gov/druginfo/meds/a604030.html (last accessed May 27, 2025) (Cymbalta); Venlafaxine, MedlinePlus, http://medlineplus.gov/druginfo/meds/a694020.html (last accessed May 27, 2025) (Effexor). Abilify is a brand-name antipsychotic typically prescribed to treat schizophrenia but can be prescribed alongside an antidepressant to treat depression when the antidepressant alone is insufficient. See Aripiprazole, MedlinePlus, http://medlineplus.gov/druginfo/meds/a603012.html (last accessed May 27, 2025). 2 Pristiq is a brand-name medication prescribed to treat depression. See Desvenlafaxine, MedlinePlus, http://medlineplus.gov/druginfo/meds/a608022.html (last accessed May 27, 2025). feeling restless with increased feelings of anxiety from taking Abilify. (Tr. 284). The nurse ordered Mr. Heenan to take a lower dose of Abilify for one week and then stop the medication. (Id.). On February 14, Mr. Heenan met with Dr. Shah and reported feelings of depression and

anxiety. (Tr. 285). Dr. Shah continued Abilify and Pristiq and added lamotrigine3 with instructions for Mr. Heenan to double the initial dosage after one week. (Id.). On February 28, Mr. Heenan admitted he did not increase the dose of lamotrigine as instructed. (Tr. 286). Dr. Shah directed Mr. Heenan to take 50 mg for one week and increase to 75 mg thereafter. (Id.). On March 16, Mr. Heenan met with Dr. Shah’s nurse practitioner and reported some improvement. (Tr. 287). He was directed to increase lamotrigine to 100 mg a day. (Id.).

On April 14, Mr. Heenan presented at a telehealth session with Dr. Shah’s nurse practitioner and reported feeling down. (Tr. 288). He expressed dissatisfaction with his job that significantly affects his mood. (Id.). On April 28, Mr. Heenan and his girlfriend presented at a telehealth session with Dr. Shah’s nurse practitioner. (Tr. 289). Mr. Heenan’s girlfriend reported he continued to be depressed and anxious, with low energy and motivation. (Id.). He expressed feeling no improvement in the past two weeks. (Id.). The nurse directed Mr. Heenan to continue Pristiq, gradually stop Abilify, and start Zoloft.4 (Id.).

3 Lamotrigine is an anticonvulsant prescribed to increase the time between episodes of depression, though it does not treat the actual episodes. See Lamotrigine, MedlinePlus, https://medlineplus.gov/druginfo/meds/a695007.html (last accessed May 27, 2025). 4 Zoloft is a brand-name medication prescribed to treat depression and anxiety. See Sertraline, MedlinePlus, https://medlineplus.gov/druginfo/meds/a697048.html (last accessed May 27, 2025). On May 12, Mr. Heenan presented at a telehealth session with Dr. Shah’s nurse practitioner and reported starting Zoloft two days before the session. (Tr. 290). He agreed to continue his medications to give the Zoloft more time to work. (Id.).

On May 26, at Mr. Heenan’s telehealth session, he described no improvement with Zoloft. (Tr. 291). The nurse practitioner continued Pristiq and lamotrigine, discontinued Zoloft, and prescribed Rexulti.5 (Id.). On June 5, Mr. Heenan presented at a telehealth session with Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Heenan v. Commissioner of Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/heenan-v-commissioner-of-social-security-administration-ohnd-2025.